Qualitative study of community perspectives and experiences with GLP-1 drugs captures patient voices on access, expectations, experiences, and concerns.
Key findingQualitative study of community perspectives and experiences with GLP-1 drugs captures patient voices
What the researchers found
Qualitative study of community perspectives and experiences with GLP-1 drugs captures patient voices on access, expectations, experiences, and concerns.
Why it matters
Relevant to peptide therapeutics.
How the study worked
In publication.
What this study cannot tell us
In publication.
How to read the evidence
Based on design.
When this study was published
Published in 2025.
The bigger picture
Advances peptide evidence.
Questions still open
- Long-term implications?
- Evidence comparison?
- Next steps?
Common questions
What does this mean?
How reliable?
Read the original research
What are community perspectives and experiences around GLP-1 receptor agonist medications for weight loss? A cross-sectional survey study in the UK.
BMJ public health, 3(2), e002519
Citation
Auerbach, Nadja; Liu, Vivian N; Huang, David Roy; Clift, Ashley Kieran; Al-Ammouri, Mahmoud; El-Osta, Austen. (2025). What are community perspectives and experiences around GLP-1 receptor agonist medications for weight loss? A cross-sectional survey study in the UK.. BMJ public health, 3(2), e002519. https://doi.org/10.1136/bmjph-2024-002519